MARKET

AIM

AIM

Aim Immunotech
AMEX
0.3974
+0.0001
+0.03%
Opening 14:01 06/20 EDT
OPEN
0.3975
PREV CLOSE
0.3973
HIGH
0.4100
LOW
0.3902
VOLUME
76.22K
TURNOVER
0
52 WEEK HIGH
0.7487
52 WEEK LOW
0.3054
MARKET CAP
22.71M
P/E (TTM)
-0.6240
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AIM last week (0610-0614)?
Weekly Report · 3d ago
Weekly Report: what happened at AIM last week (0603-0607)?
Weekly Report · 06/10 10:18
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
AIM ImmunoTech Inc. Will participate in the Virtual Investor Pitch Conference on Monday, June 17, 2024. Thomas K. Equels, MS JD, Chief Executive Officer of AIM will attend the conference. The conference will be held in New York City, New York.
Barchart · 06/10 07:55
Weekly Report: what happened at AIM last week (0527-0531)?
Weekly Report · 06/03 10:20
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
AIM ImmunoTech Inc. Will participate in the Virtual Investor Lunch Break Series on Wednesday, June 5, 2024 at 12:00 PM ET. Thomas K. Equels, MS JD, Chief Executive Officer of AIM will be in attendance. AIM immunoTech is a leading biotech company.
Barchart · 06/03 08:15
Weekly Report: what happened at AIM last week (0520-0524)?
Weekly Report · 05/27 10:23
Weekly Report: what happened at AIM last week (0513-0517)?
Weekly Report · 05/20 10:19
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
Barchart · 05/20 08:15
More
About AIM
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called Ampligen (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Webull offers AIM ImmunoTech Inc stock information, including AMEX: AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.